Dallas, TX, August 16, 2013 --(PR.com
)-- Hyperion Medical is proud to announce the availability of the FDA approved SudoScan device to the medical community. The SudoScan device is a new solution for Sudorimetry, measuring of the sweat gland function as a biomarker for ANS function. Sudorimetry will be the first detectable damage to the small fibers of the peripheral nervous system, before any clinical signs or symptoms. The SudoScan device utilizes a non-invasive 3 minute test of the sweat glands function via reverse ionophoresis and chronoamperometry with a 80% Sensitivity & 95% Specificity*. The SudoScan test is fast, painless, quantitative, reproducible and not technically demanding.
*Diagnostic efficiency of feet and hands ESC to reflect DPN (NIS-LL)
Vinik A, Parson H, Richardson M, Casselini C. Evaluating SudoScan as a New Diagnostic Tool for Diabetic Neuropathy and Autonomic Dysfunction.